Every dollar amount and date on this page is quoted from the official settlement document.
Erba
Court case: Tran v. ERBA Diagnostics, Inc., et al.
ERBA Diagnostics settled a securities fraud lawsuit covering investors who bought its stock on the NYSE between June 14, 2013 and November 20, 2015. The $1,215,000 settlement paid an average gross recovery of about $0.17 per share, roughly $0.11 after fees and expenses. The claim-filing window closed in 2018.
Official eligibility wordingAll persons who purchased ERBA Diagnostics, Inc. securities on the NYSE from June 14, 2013 through November 20, 2015, inclusive, excluding defendants, current/former officers and directors of ERBA and MHM, and their family members. Checked against the official settlement source by SettleSignal on June 18, 2026.
Key facts
- Who may qualify Anyone who purchased or otherwise acquired ERBA Diagnostics, Inc. securities on the NYSE between June 14, 2013 and November 20, 2015 was covered, excluding the defendants, ERBA's and MHM's officers and directors, and their immediate family members.
- Estimated payout$1,215,000 total settlement; average gross recovery of $0.17 per share; approximately $0.11 per damaged share after fees and expenses.
- Claim deadlineDecember 10, 2018 (closed)
- Proof requiredYes
- What you needThe December 10, 2018 claim deadline has passed, and no new claims are being accepted.
- CourtUnited States District Court for the Southern District of Florida
Important dates
How hard is this claim to file?
Documents you'll need
Watch out for
- The deadline to file a claim has passed — this settlement is marked Complete; no new claims can be submitted
- Doing nothing results in no payment AND a loss of your legal rights against Defendants
- If you excluded yourself from the class, you cannot receive a payment but retain the right to sue separately
- Officers, directors, and certain family members of ERBA and MHM are excluded and cannot file
We prepare — you file on the official site yourself. This is not legal advice and is not an eligibility decision; the administrator and court decide.
Verify it yourself
How we verified this record
- Claim deadline
- Payout details
- Eligibility
- Proof requirement
- Administrator
- Court case
- Payment status
- 1 field queued for re-check
1 official source linked to this record.
-
Claim deadline
December 10, 2018
SUBMIT A CLAIM FORM NO LATER THAN DECEMBER 10, 2018 The only way to get a payment.
-
Eligibility summary Quoted in the official eligibility wording above ↑
The Settlement Class consists of all Persons (including, without limitation, their beneficiaries) who purchased ERBA securities on the NYSE from June 14, 2013 through November 20, 2015, inclusive.
-
Proof requirement
Yes
-
Payment status
Distribution complete
Case Status: Complete.
-
Estimated payout
$1,215,000 total settlement; average gross recovery of $0.17 per share; approximately $0.11 per damaged share after fees and expenses.
The Settlement represents an average gross recovery of $0.17 per share of ERBA securities for the approximately 7.15 million estimated shares eligible for a payment.
-
Administrator
Strategic Claims Services
Show all 7 more verified fields
-
Objection deadline
January 9, 2019
OBJECT NO LATER THAN JANUARY 9, 2019 Write to the Court about why you do not like the Settlement.
-
Opt-out deadline
December 10, 2018
EXCLUDE YOURSELF NO LATER THAN DECEMBER 10, 2018 Get no payment. This is the only option that allows you to ever be part of any other lawsuit against Defendants about the legal claims in this case.
-
Class period start
June 14, 2013
-
Class period end
November 20, 2015
-
Court
United States District Court for the Southern District of Florida
-
Court case number
15-cv-24440-COOKE/TORRES
-
Case name
Tran v. ERBA Diagnostics, Inc., et al.
The case is known as Tran v. ERBA Diagnostics, Inc., et al., Case No.15-cv-24440 (S.D. Fla.) (the "Action"), and the Court in charge of the case is the United States District Court for the Southern District of Florida.
Where to act
